Global Remdesivir Market, By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies), By Region, Competition Forecast & Opportunities, 2026
Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.
The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe.Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe.
The Chinese have also been using the drug on compassionate use basis.Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington.
He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration.A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir.
Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well.
The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region.Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution.
The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.
Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.
Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.
Years considered for this report:
Base Year: 2020 Estimated Year: 2021E Forecast Period: 2022F–2026F
Objective of the Study:
• To analyze and estimate the market size of global remdesivir market in 2020. • To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026. • To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution. • To identify dominant region or segment in the global remdesivir market. • To identify drivers and challenges for global remdesivir market. • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market. • To conduct pricing analysis for global remdesivir market. • To identify and analyze the profile of leading players operating in global remdesivir market. • To identify key sustainable strategies adopted by market players in global remdesivir market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the globe.
Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.
Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the globe. The analyst calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.
Key Target Audience:
• Remdesivir manufacturers, suppliers, distributors and other stakeholders • Government bodies such as regulating authorities and policy makers • Organizations, forums and alliances related to remdesivir • Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • Global Remdesivir Market, By Dosage Form: o Lyophilized Solution o Frozen Solution • Global Remdesivir Market, By Route of Administration: o Intravenous o Inhalation • Global Remdesivir Market, By Patient Age: o Geriatric o Adult o Pediatric • Global Remdesivir Market, By Application: o SARS-CoV-2 (COVID-19) o MERS-CoV o Ebola o SARS-CoV • Global Remdesivir Market, By Distribution Channel: o Hospitals o Clinics o Drug Stores and Pharmacies • Global Remdesivir Market, By Region: o North America United States Mexico Canada o Asia-Pacific India Japan China South Korea Australia o Europe France United Kingdom Italy Germany Spain o South America Brazil Argentina Colombia o Middle East & Africa Iran South Africa UAE Saudi Arabia Kuwait
Company Profiles: Detailed analysis of the major companies present in global remdesivir market.
With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
Our reports have been used by over 10K customers, including:
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
129 pages •
By Global Industry Analysts
• Aug 2021
Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...
The global apheresis equipment market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC and SLM Solutions Group AG. The global 3D printed implants market is expected to grow from $0.14 billion in 2020 to $0.15 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies...
Anatomic Pathology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology types, applications. Further, Anatomic Pathology...
Anatomic Pathology Track and Trace Solutions market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Track and Trace Solutions Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology...
Pathology Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pathology Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pathology Devices types, applications. Further, Pathology Devices...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
The global arthroscopy devices market exhibited moderate growth during 2015-2020. Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body. They are primarily used for the treatment of medical conditions,...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.